Cellular and Molecular Bioengineering

Scope & Guideline

Bridging Disciplines for Groundbreaking Scientific Discovery

Introduction

Immerse yourself in the scholarly insights of Cellular and Molecular Bioengineering with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1865-5025
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2009 to 2024
AbbreviationCELL MOL BIOENG / Cell. Mol. Bioeng.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The journal 'Cellular and Molecular Bioengineering' focuses on the intersection of cellular biology and bioengineering, with an emphasis on innovative technologies and methodologies that advance our understanding of cellular functions and therapeutic applications. It covers a broad range of topics that contribute to the fields of tissue engineering, regenerative medicine, and cellular therapy.
  1. Tissue Engineering and Regenerative Medicine:
    Research exploring the development and application of biomaterials and scaffolds for the regeneration of tissues and organs, including the engineering of extracellular matrices and stem cell therapies.
  2. Cellular Mechanotransduction:
    Investigations into how cells sense and respond to mechanical stimuli, which plays a crucial role in various physiological and pathological processes.
  3. Microfluidic and Organ-on-a-Chip Technologies:
    Innovative designs and applications of microfluidic systems that simulate human organ functions, facilitating drug testing and disease modeling.
  4. Synthetic Biology and Genetic Engineering:
    Studies focused on the design of novel biological parts and systems, including the use of engineered proteins and genetic circuits for therapeutic applications.
  5. Cancer Biology and Therapeutics:
    Research on the cellular and molecular mechanisms underlying cancer progression and metastasis, along with the development of targeted therapies and drug delivery systems.
  6. Extracellular Vesicles and Cell Communication:
    Exploration of the role of extracellular vesicles in intercellular communication and their potential as therapeutic agents.
  7. Biophysical Characterization of Cells:
    Utilization of biophysical techniques to characterize cellular behavior, including studies on cell motility, adhesion, and mechanical properties.
The journal 'Cellular and Molecular Bioengineering' reflects emerging trends and themes that are gaining traction in the field. Recent publications indicate a shift towards innovative methodologies and interdisciplinary approaches that address current challenges in bioengineering and medicine.
  1. Artificial Intelligence and Machine Learning Applications:
    The integration of AI and machine learning techniques into bioengineering research is on the rise, particularly for data analysis, predictive modeling, and enhancing educational methodologies.
  2. Advanced Biomaterials and Hydrogel Technologies:
    There is a growing focus on the development of new biomaterials and hydrogels that mimic the extracellular matrix, enhancing tissue engineering applications and regenerative medicine.
  3. Intercellular Communication Mechanisms:
    Research on the role of extracellular vesicles and other forms of cell communication is increasingly important, highlighting their potential in therapeutic applications and disease modeling.
  4. Personalized Medicine and Precision Therapies:
    An emphasis on tailoring treatments based on individual patient profiles is emerging, particularly in cancer therapies and regenerative medicine, leveraging bioengineering innovations.
  5. Tumor Microenvironment Studies:
    There is a noticeable trend towards investigating the complex interactions within tumor microenvironments, utilizing novel in vitro models to better understand cancer biology and therapeutic resistance.

Declining or Waning

While 'Cellular and Molecular Bioengineering' remains at the forefront of research in cellular and molecular engineering, certain themes have shown signs of declining interest or publication frequency. These waning scopes may reflect shifts in research focus or advancements in technology that render previous methodologies less relevant.
  1. Traditional In Vitro Models:
    Research utilizing standard two-dimensional cell culture systems appears to be diminishing as the field moves toward more complex, physiologically relevant three-dimensional models.
  2. Basic Cellular Mechanisms without Therapeutic Applications:
    Studies focusing solely on fundamental cellular processes without direct applications to therapy or engineering solutions are becoming less prominent, as there is a growing emphasis on translational research.
  3. Single-Cell Analysis Technologies:
    Although still important, there seems to be a reduction in the number of publications solely dedicated to single-cell sequencing or profiling technologies, as these methods become more integrated into broader studies.
  4. Animal Models for Drug Testing:
    Research relying heavily on traditional animal models for drug testing is declining in favor of human-relevant models such as organ-on-a-chip systems.

Similar Journals

BIOLOGY OF THE CELL

Unveiling the secrets of life, one cell at a time.
Publisher: WILEYISSN: 0248-4900Frequency: 12 issues/year

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.

Stem Cell Research & Therapy

Exploring Breakthroughs in Stem Cell Biology
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Illuminating Cellular Processes Through Open Access Research
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

EXPERIMENTAL CELL RESEARCH

Shaping the Future of Cell Science
Publisher: ELSEVIER INCISSN: 0014-4827Frequency: 20 issues/year

EXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.

Regenerative Medicine

Charting New Territories in Regenerative Medicine
Publisher: TAYLOR & FRANCIS LTDISSN: 1746-0751Frequency: 12 issues/year

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

APL Bioengineering

Empowering Discoveries in Bioengineering and Beyond
Publisher: AIP PublishingISSN: 2473-2877Frequency: 4 issues/year

APL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.

CELL AND TISSUE RESEARCH

Championing Quality Research in Histology and Cell Dynamics
Publisher: SPRINGERISSN: 0302-766XFrequency: 12 issues/year

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

Biofabrication

Exploring Breakthroughs in Biofabrication Research.
Publisher: IOP Publishing LtdISSN: 1758-5082Frequency: 4 issues/year

Biofabrication, published by IOP Publishing Ltd, stands at the forefront of the interdisciplinary fields of biochemistry, bioengineering, biomaterials, biomedical engineering, biotechnology, and miscellaneous medicine. Since its inception in 2009, this prestigious journal has secured its position within the Q1 category across multiple disciplines as of 2023, reflecting its high impact and significant contribution to advancing research in these domains. With ranks such as #19 in biochemistry and #10 in biomaterials according to Scopus, it showcases groundbreaking studies and innovative methodologies that are crucial for the evolution of biofabrication technologies. Authored by leading researchers and professionals, the journal publishes articles that explore the synthesis, characterization, and application of biomaterials, providing valuable insights for both academic researchers and industry practitioners. The impact factor of the journal, combined with its rigorous peer-review process, guarantees high-quality content that pushes the boundaries of knowledge and technology. Researchers and students engaged in these dynamic fields will find Biofabrication an indispensable resource for staying abreast of critical developments and emerging trends.

MOLECULAR BIOLOGY OF THE CELL

Transforming Understanding of Cellular Processes
Publisher: AMER SOC CELL BIOLOGYISSN: 1059-1524Frequency: 13 issues/year

MOLECULAR BIOLOGY OF THE CELL is a prestigious journal published by the American Society for Cell Biology, focusing on the latest advancements in cell biology and molecular biology. Established in 1990, this journal serves as a vital forum for disseminating innovative research, methodologies, and insights that drive the understanding of cellular processes and their implications in health and disease. With a noteworthy impact factor and recognition within the top quartiles for both Cell Biology and Molecular Biology, it ranks prominently among its peers, with Scopus rankings reflecting its significance in the scientific community. Although the journal does not follow an open access model, it provides essential access options for both institutional and personal subscriptions. Researchers, professionals, and students seeking to expand their knowledge and collaborate on groundbreaking findings will find MOLECULAR BIOLOGY OF THE CELL an invaluable resource in the field.

Cell Communication and Signaling

Exploring the Nuances of Molecular Signaling
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.